Balyasny Asset Management’s Stemline Therapeutics, Inc. STML Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-17,400
Closed -$193K 2112
2017
Q3
$193K Buy
+17,400
New +$193K ﹤0.01% 1512
2016
Q1
Sell
-14,230
Closed -$90K 1410
2015
Q4
$90K Buy
+14,230
New +$90K ﹤0.01% 1035
2015
Q1
Sell
-149,477
Closed -$2.55M 903
2014
Q4
$2.55M Buy
+149,477
New +$2.55M 0.02% 378